BioCentury
ARTICLE | Strategy

The ramifications of an American Cyanamid buyout

August 8, 1994 7:00 AM UTC

Like most other upheavals, the ramifications of the potential acquisition of American Cyanamid by American Home Products, SmithKline Beecham or any other bidder, will affect actors peripheral to the central drama.

In this case, those potentially affected by the fallout from last week's buyout offer from American Home are Cyanamid's corporate partners, including Quadra Logic Technologies Inc., Houghten Pharmaceuticals Inc. and MedImmune Inc...